Real-World Outcomes of First-Line Treatment of Metastatic or Locally Advanced Upper Tract Urothelial Carcinoma With Enfortumab Vedotin Plus Pembrolizumab : A French Multicenter Retrospective Observational Study

NCT07633353 · clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Centre Hospitalier Universitaire de Nīmes